Skip to main content

Calpastatin (the Endogenous Calpain Inhibitor) and Membrane Protein Degradation in Cell Fusion

  • Protocol
Book cover Calpain Methods and Protocols

Part of the book series: Methods in Molecular Biology™ ((MIMB,volume 144))

Abstract

Cell membrane fusion is a ubiquitous cellular process, mediating such phenomena as fertilization, muscle development, certain viral infections, and giant cell formation from macrophages. For membrane fusion to occur, the cell membranes must attach to each other, usually by means of interactions between membrane receptors. Increased cellular Ca2+ is required for the various fusion events, and changes occur in the cell membrane and cytoskeleton. Fusion of membranes occurs between the two phospholipid bilayers in regions that are poor in proteins (fusion-potent domains). It has been proposed that membrane protein degradation contributes to the disorganization of cell membrane and cytoskeleton in preparation for the fusion of the cell membranes (13).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Yanagimachi R. (1988) Sperm-egg fusion. Curr. Top. Membr. Transp. 32, 3–43.

    Google Scholar 

  2. Wakelam M. J. O. (1988) Myoblast fusion: a mechanistic analysis. Curr. Top.Membr. Transp. 32, 87–112.

    Google Scholar 

  3. Okada Y. (1988) Sendai virus-mediated cell fusion. Curr. Top. Membr. Transp.32, 297–336.

    Google Scholar 

  4. Murachi T. (1984) Calcium-dependent proteinase and specific inhibitors: Calpain and calpastatin. Biochem. Soc. Symp. 49, 149–167.

    PubMed  CAS  Google Scholar 

  5. Ahkong Q. F., Fisher D., Tampion W., and Lucy J. A. (1975) Mechanisms of cell fusion. Nature 253, 194–195.

    Article  PubMed  CAS  Google Scholar 

  6. Kosower E. M., Kosower N. S., and Wegman P. (1977) Membrane Mobility agents. V: The mechanism of particle-cell and cell-cell fusion. Biochim. Biophys. Acta 471, 311–329.

    Article  PubMed  CAS  Google Scholar 

  7. Kosower N. S., Glaser T., and Kosower E. M. (1983) Membrane-mobility agent-promoted fusion of erythrocyte: Fusibility is correlated with attack by calcium-activated cytoplasmic proteases on membrane proteins. Proc. Natl. Acad. Sci. U.S.A. 80, 7542–7546.

    Article  PubMed  CAS  Google Scholar 

  8. Kosower N. S. and Glaser T. (1990) The calpain-calpastatin system and membrane fusion, in Intracellular Calcium-Dependent Proteolysis (Mellgren R. L. and Murachi T., eds.) CRC Press Boca Raton, FL. pp. 163–180.

    Google Scholar 

  9. Barnoy S., Glaser T., and Kosower N.S. (1996) The role of calpastatin (the specifc calpain inhibitor) in myoblast differentiation and fusion. Biochem. Biophys. Res. Commun. 220, 933–938.

    Article  PubMed  CAS  Google Scholar 

  10. Barnoy S., Glaser T., and Kosower N. S. (1997) Calpain and calpastatin in myoblast differentiation and fusion: Effects of inhibitors. Biochim. Biophys. Acta 1358, 181–188.

    Article  PubMed  CAS  Google Scholar 

  11. Barnoy S., Glaser T., and Kosower N. S. (1998) The calpain-calpastatin system and protein degradation in fusing myoblasts. Biochim. Biophys. Acta 1402, 52–60.

    Article  PubMed  CAS  Google Scholar 

  12. Raser K. J., Posner A., and Wang K. K. W. (1995) Casein zymography: A method to study μ-calpain, m-calpain and their inhibitory agents. Arch. Biochem. Biophys. 319, 211–216.

    Article  PubMed  CAS  Google Scholar 

  13. Hayashi M., Saito Y., and Kawashima S. (1992) Calpain activation is essential for membrane fusion of erythrocytes in the presence of exogenous Ca2+. Biochem. Biophys. Res. Commun. 182, 939–946.

    Article  PubMed  CAS  Google Scholar 

  14. Ross E. and Schatz G. (1973) Assay of protein in the presence of high concentrations of sulfhydryl compounds. Anal. Biochem. 54, 304–306.

    Article  PubMed  CAS  Google Scholar 

  15. Massague J., Cheifetz S., Endo T., and Nadal-Ginard B. (1986) Type β transforming growth factor is an inhibitor of myogenic differentiation. Proc. Natl.Acad. Sci. U.S.A. 83, 8206–8210.

    Article  PubMed  CAS  Google Scholar 

  16. Schwarz-Benmeir N., Glaser T., Barnoy S., and Kosower N.S. (1994) Calpastatin in erythrocytes of young and old individuals. Biochem. J. 304, 365–370.

    PubMed  CAS  Google Scholar 

  17. Glaser T. and Kosower N.S. (1986) Calpain-calpastatin and fusion: Fusibility of erythrocytes is determined by a protease-protease inhibitor (calpain-calpastatin) balance FEBS Lett. 206, 115–120.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Humana Press Inc.

About this protocol

Cite this protocol

Kosower, N.S., Barnoy, S. (2000). Calpastatin (the Endogenous Calpain Inhibitor) and Membrane Protein Degradation in Cell Fusion. In: Elce, J.S. (eds) Calpain Methods and Protocols. Methods in Molecular Biology™, vol 144. Humana Press. https://doi.org/10.1385/1-59259-050-0:181

Download citation

  • DOI: https://doi.org/10.1385/1-59259-050-0:181

  • Publisher Name: Humana Press

  • Print ISBN: 978-0-89603-632-1

  • Online ISBN: 978-1-59259-050-6

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics